MDMA’s Leahey Sees Reasons for Concern and Optimism
Author
Healthegy
Published
Wed 29 Apr 2015
Episode Link
None
Mark Leahey of the MDMA explains how a move against patent troll could cut the legs out from Medtech entrepreneurs and VCs dependent upon IP protection.
